About Inbio Ventures
Inbio Ventures is a Financial Services company based in Moscow (Russia). Early-stage life sciences investments are made globally by Inbio Ventures. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
Inbio Ventures is based in Moscow, Russia, where early-stage venture capital is directed toward life sciences sectors, including biopharma. Global investments are pursued to support innovative companies in these fields. Operations encompass funding for biotechnology and pharmaceutical startups. The portfolio features companies such as Neon Therapeutics, Allena Pharmaceuticals, Aquinox Pharmaceuticals, and EnGene, reflecting a commitment to therapeutic advancements.
- Headquarters Moscow, Russia
- SectorsFinancial Services
- Website inbio-ventures.com
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Inbio Ventures
Complete news archive for Inbio Ventures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inbio Ventures
Inbio Ventures is headquartered in Moscow, Russia.
Inbio Ventures is based in Moscow, Russia, where early-stage venture capital is directed toward life sciences sectors, including biopharma. Global investments are pursued to support innovative companies in these fields. Operations encompass funding for biotechnology and pharmaceutical startups. The portfolio features companies such as Neon Therapeutics, Allena Pharmaceuticals, Aquinox Pharmaceuticals, and EnGene, reflecting a commitment to therapeutic advancements.